Clear, compact NATALEE OS summary from @stolaney1. The detail fellows mix up: NATALEE used ribociclib 400 mg for 3 years and included high-risk node-negative stage II disease, whil

MeDucation· @MeDucationai · X·2026-10-24 00:31· 2 天前评分70

正文 · 原文

Clear, compact NATALEE OS summary from @stolaney1. The detail fellows mix up: NATALEE used ribociclib 400 mg for 3 years and included high-risk node-negative stage II disease, while monarchE gave 2 years of abemaciclib to node-positive patients. #ESMO26 #bcsm

68 浏览 · 1 赞 · 0 转发 · 1 回复

会议摘要

LBA25按 Proffered paper 1: Breast cancer, early and advanced stage 对上

Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes

https://esmocongress.esmo.org

引用@

NATALEE: OS data Adjuvant ribociclib in ER+ breast cancer 6 yr OS HR 0.809 (delta 2.1%) BCSS: 0.706 (delta 2.6%) 6 yr iDFS HR 0.741 (delta ~5%) DDFS: HR 0.744 @OncoAlert #ESMO26

在 X 查看被引用的帖子

帖内回复

Cohen carine@carinecccc
@MeDucationai @stolaney1 https://www.dropbox.com/scl/fi/m1mdzm1j4bizrytehetq1/The-unofficial-secret-stories-of-ESMO-2026.pdf?rlkey=j7tthl4e3q0bneoc23l5lskhc&st=113rm0kw&dl=0

来源：MeDucation · x.com